Abstract:Objective: Disruption of B cell homeostasis and subsequent dominance of effector B cell subsets are critical for the development of systemic lupus erythematosus (SLE). Revealing the key intrinsic regulators involved in the homeostatic control of B cells has important therapeutic value for SLE. This study was undertaken to determine the regulatory role of the transcription factor Pbx1 in B cell homeostasis and lupus pathogenesis. Methods: We constructed mice with B cell-specific deletion of Pbx1. T cell-dependent and T cell-independent humoral responses were induced by intraperitoneal injection of nitrophenyl-containing hapten (NP) conjugated to keyhole limpet hemocyanin or NP-Ficoll. The regulatory effects of Pbx1 on autoimmunity were observed in a Bm12-induced lupus murine model. We investigated mechanisms of Pbx1 using RNA sequencing, the cleavage under targets and tagmentation assay, and chromatin immunoprecipitation-quantitative polymerase chain reaction assay. We transduced B cells from SLE patients with plasmids that overexpressed PBX1 to explore the in vitro therapeutic efficacy of PBX1. Results: Pbx1 was specifically down-regulated in autoimmune B cells and negatively correlated with disease activity. The deficiency of Pbx1 in B cells resulted in excessive humoral responses following immunization. In the Bm12-induced lupus model, mice with B cell-specific Pbx1 deficiency displayed enhancements in germinal center responses, plasma cell differentiation, and autoantibody production. Pbx1-deficient B cells had increased survival and proliferative advantages after activation. Pbx1 regulated genetic programs by directly targeting critical components of the proliferation and apoptosis pathways. In SLE patients, PBX1 expression was negatively correlated with effector B cell expansion; when PBX1 expression was enforced, the survival and proliferative capacity of SLE B cells were attenuated. Conclusion: Our study reveals the regulatory function and mechanism of Pbx1 in adjusting B cell homeostasis and highlights Pbx1 as a therapeutic target in SLE.

HSP70, a Novel Regulatory Molecule in B Cell-Mediated Suppression of Autoimmune Diseases.

Generation Of Human Regulatory Gamma Delta T Cells By Tcr Gamma Delta Stimulation In The Presence Of Tgf-Beta And Their Involvement In The Pathogenesis Of Systemic Lupus Erythematosus

Regulatory B cells in autoimmune diseases

Regulatory B Cells—Immunopathological and Prognostic Potential in Humans

Progress of regulatory B cell's immunosuppression against tumor immunity

Regulatory B cells:research advances

Regulatory B Cells and Autoimmune Diseases

Immunosuppressive Mechanisms of Regulatory B Cells

Heat Shock Protein 70 as a Double Agent Acting Inside and Outside the Cell: Insights into Autoimmunity

The Er Membrane-Anchored Ubiquitin Ligase Hrd1 is A Positive Regulator of T-Cell Immunity

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

Immunomodulation of Human CD19+CD25high Regulatory B Cells Via Th17/Foxp3 Regulatory T Cells and Th1/Th2 Cytokines.

Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases

Releasing Pathways and Immune Function of Extracellular Heat Shock Protein 70

CD70-mediated CD27 Expression Downregulation Contributed to the Regulatory B10 Cell Impairment in Rheumatoid Arthritis.

Heat Shock Protein 90 is Critical for Regulation of Phenotype and Functional Activity of Human T Lymphocytes and NK Cells.

Regulatory B cells in autoimmune diseases and mucosal immune homeostasis

The characteristics of regulatory B cells and their functions in diseases

LSO-002 the Transcriptional Factor Pbx1 Adjusts Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity

Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity

[Research Progress in B10 Cells and Autoimmune Diseases].